22.25 USD
↘ 0.87 (3.76%)AT CLOSE (11:59 AM EDT)
CareDx, Inc.
CDNANASDAQ • USD
22.10
↘ 0.15 (0.67%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
22.10
↘ 0.15 (0.67%)
Market: CLOSED
Open?$23.16
High?$23.51
Low?$22.03
Prev. Close?$23.12
Volume?548.4K
Avg. Volume?734.4K
VWAP?$22.40
Rel. Volume?0.75x
Bid / Ask
Bid?$21.75 × 200
Ask?$24.70 × 2.0K
Spread?$2.95
Midpoint?$23.23
Valuation & Ratios
Market Cap?1.2B
Shares Out?51.7M
Float?49.0M
Float %?95.3%
P/E Ratio?N/A
P/B Ratio?3.81
EPS?-$0.16
Dividend?0.00%
Ex-Dividend?N/A
CareDx, Inc. (CDNA) is currently trading at $22.25. The stock presents a bullish profile across the board: both technical indicators and our fundamental models signal a "Strong Buy" and "Buy" respectively. Notable factors include a robust Altman Z-Score, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Jun 5, 2026.
News
Profile
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
Themes
Employees
765
Market Cap
1.2B
Industry
SERVICES-MEDICAL LABORATORIES
Website
Listed
2014-07-17
Address
8000 MARINA BLVD
BRISBANE, CA 94005
Phone: 415-287-2300
BRISBANE, CA 94005
Phone: 415-287-2300
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?60
Z-Score?100
Momentum?92
Short Sent.?53
Piotroski F-Score?5/9Mixed
Altman Z-Score?9.82Safe
Confidence?64%Moderate
Short InterestVery High
Short % of Float?13.27%High
Short Interest?6.5M
Days to Cover?11.3
Free Float49.0M
Avg Daily Volume574.5K
Settlement Date2026-05-15
Financial Health
Current Ratio?3.40Strong
Quick Ratio?3.07Strong
Cash Ratio?0.98Adequate
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score80/100
P/E?N/A▾
P/B?3.81FAIR▾
Peers100
S&P46
P/S?2.89CHEAP▾
Peers100
S&P52
P/FCF?18.4CHEAP▾
Peers100
S&P61
EV/EBITDA?19,249.0HIGH▾
Peers100
S&P3
EV/Sales?2.70CHEAP▾
Peers100
S&P65
Returns & Efficiency
ROE?-2.6%WEAK▾
S&P13
ROA?-2.0%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$64.8M
Enterprise Value?$1.1B
Fundamentals ratios updated end of day